Table 1 Antifungal therapy in cryptococcal meningitis
Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript. Advertisement From: Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy Nature Reviews Neurology (Nat Rev Neurol) ISSN 1759-4766 (online) ISSN 1759-4758 (print) © 2022 Springer Nature Limited
Table 1 Antifungal therapy in cryptococcal meningitis | Nature Reviews Neurology Skip to main content Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript. Advertisement Stage Pharmacological treatment regimen Duration Induction L-AmB 3–6 mg/kg daily or D-AmB 0.7–1.0 mg/kg daily (L-AmB preferred in organ transplant pat
related reading
- Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy | Nature Reviews Neurologynature.com
- Treatment of HIV-associated primary CNS lymphoma with antiretroviral therapy, rituximab, and high-dose methotrexatencbi.nlm.nih.gov
- The amyloid hypothesis in Alzheimer disease: new insights from new therapeuticsnature.com
- Interleukin-6 Blockade as Rescue Therapy in Autoimmune Encephalitis - PMCncbi.nlm.nih.gov
- Transcranial ultrafast ultrasound localization microscopy of brain vasculature in patientsnature.com
- Engram neurons: Encoding, consolidation, retrieval, and forgetting of memorynature.com
- Genetic susceptibility to Candida infectionsncbi.nlm.nih.gov
- Levofloxacin - StatPearls - NCBI Bookshelfncbi.nlm.nih.gov
- Frontiers | Transient multidomain functional improvement in advanced Alzheimer’s disease following high-dose psilocybin-containing mushroom administration: a case reportfrontiersin.org
- Multiresistant Fusarium Pathogens on Plants and Humans: Solutions in (from) the Antifungal Pipeline? - PMCncbi.nlm.nih.gov
- Identifying dysfunctional cell types and circuits in animal models for psychiatric disorders with calcium imagingnature.com
- CG-dinucleotide suppression enables antiviral defense targeting non-self RNA - PMCncbi.nlm.nih.gov